FAAH inhibitor URB597 shows anti‐hyperalgesic action and increases brain and intestinal tissues fatty acid amides in a model of CRF1 agonist mediated visceral hypersensitivity in male rats
Muriel Larauche,Agata Mulak,Chrysanthy Ha,Mulugeta Million,Stacy Arnett,Peter Germano,James P. Pearson,Mark G. Currie,Yvette Taché
DOI: https://doi.org/10.1111/nmo.14927
2024-10-01
Neurogastroenterology & Motility
Abstract:The fatty acid amide hydrolase (FAAH) enzyme inhibitor, URB597, increases brain and intestine levels of endocannabinoid anandamide and other FAAs and suppresses peripheral CRF1 receptor activation‐induced visceral hypersensitivity to colorectal distension, but not the secretomotor response in male rats, supporting potential use of FAAH inhibitors for stress‐sensitive visceral pain disorders. Background and Aims The endocannabinoid (eCB) system includes ligands (anandamide and 2‐arachidonoyl glycerol, 2‐AG), receptors and catabolizing enzymes (fatty acid amide hydrolase, FAAH and monoacylglycerol lipase) expressed in both the brain and gut. We investigated whether the FAAH inhibitor, URB597, influenced visceral pain to colorectal distension (CRD) in an acute stress‐related model of visceral hypersensitivity induced by the selective corticotropin‐releasing factor receptor subtype 1 (CRF1) agonist, cortagine. Methods Male Sprague–Dawley rats were injected subcutaneously (SC) with URB597 (3 mg/kg) or vehicle and 2 h later, intraperitoneally with cortagine (10 μg/kg) or vehicle. The visceromotor responses (VMR) were assessed to a first CRD (baseline) before injections, and to a second CRD 15 min after the last treatment. Brain, jejunum, and proximal colon were collected from treated and naïve rats for levels quantification of three fatty acid amides (FAAs) [anandamide (arachidonyl‐ethanolamide, AEA), oleoyl‐ethanolamide (OEA) and palmitoyl‐ethanolamide (PEA)], and 2‐AG. In separate animals, defecation/diarrhea were monitored after URB597 and cortagine. Key Results URB597 inhibited cortagine‐induced increased VMR at 40 mmHg (89.0 ± 14.8% vs. 132.5 ± 15.6% for vehicle SC, p
gastroenterology & hepatology,neurosciences,clinical neurology